This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Teladoc Stock Near 52-Week Low: Is it Healthy Enough to Invest?
by Zacks Equity Research
TDOC is well positioned to grow in the long run on the back of expanding product offerings, memberships, AI integration, business diversification and global expansions.
American Well (AMWL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for American Well (AMWL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
American Well Corporation (AMWL) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
American Well (AMWL) delivered earnings and revenue surprises of 14.72% and 3.30%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Will American Well Corporation (AMWL) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
American Well (AMWL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Compared to Estimates, American Well (AMWL) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
American Well Corporation (AMWL) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
American Well (AMWL) delivered earnings and revenue surprises of -38.89% and 2.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
American Well Corporation (AMWL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for American Well Corporation (AMWL) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
American Well Corporation (AMWL) delivered earnings and revenue surprises of 10.53% and 1%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
American Well Corporation (AMWL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for American Well Corporation (AMWL) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
American Well Corporation (AMWL) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for American Well Corporation (AMWL) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
American Well Corporation (AMWL) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
American Well Corporation (AMWL) delivered earnings and revenue surprises of -9.52% and 4.59%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Will American Well Corporation (AMWL) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
American Well Corporation (AMWL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
American Well Corporation (AMWL) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
American Well Corporation (AMWL) delivered earnings and revenue surprises of -20% and 2%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
American Well Corporation (AMWL) delivered earnings and revenue surprises of 12% and 1.93%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
American Well Corporation (AMWL) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
American Well Corporation (AMWL) delivered earnings and revenue surprises of 3.85% and 0.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
American Well Corporation (AMWL) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
American Well Corporation (AMWL) delivered earnings and revenue surprises of 0% and 3.56%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
American Well Corporation (AMWL) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
American Well Corporation (AMWL) delivered earnings and revenue surprises of -18.18% and 0.67%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for American Well (AMWL)
by Zacks Equity Research
American Well (AMWL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
American Well Corporation (AMWL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
American Well Corporation (AMWL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Should You Stay Away From Teladoc Health (TDOC) Now?
by Zacks Equity Research
Rising competition and decreasing business volumes place Teladoc Health (TDOC) in a precarious position.
American Well (AMWL) Down 59% YTD: Should You Still Hold?
by Zacks Equity Research
American Well (AMWL) is well placed in the booming telehealth industry on the back of its organic and inorganic growth profiles.
Amwell (AMWL) Buys Digital Care Startups to Enhance Market Share
by Zacks Equity Research
Amwell (AMWL) acquires digital health startups for fast expansion in the telehealth market.
American Well (AMWL) Q2 Earnings Beat, 2H21 Visit View Cut
by Zacks Equity Research
American Well (AMWL) posts lower-than-expected loss for Q2. The spread of Delta variant compels the company to slash 2021 guidance.
Teladoc Health (TDOC) Q2 Loss Wider Than Expected, Worsen Y/Y
by Zacks Equity Research
Teladoc Health's (TDOC) Q2 earnings endure high expenses. Guidance shows tapering of growth.
Here's Why You Should Hold Teladoc Health (TDOC) in Your Portfolio
by Zacks Equity Research
Despite a great run on the bourses last year, Teladoc Health (TDOC) suffers tepid demand while stiff competition calls for keeping a close watch on the stock.